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Supplementary Figure 1. Heterogeneity of CD10+ cell populations in normal breast tissues. a, 
Schematic outline of the purification procedure and phenotype of the cells in cell culture. b, Combined 
analysis of cells for the expression of CD10 and CD44 cell surface markers and ALDH enzymatic 
activity. Left panel indicates staining of cells for CD10 and CD44 whereas right panel shows ALDH 
activity of cells selected based on difference in CD10 and CD44 expression. ALDH activity was 
assessed with and without DAEB (ALDH inhibitor). c, Gating strategy used for the quantification of 
CD10+CD44+ and CD10+CD44- cells.  Single cell suspension derived from organoids were stained with 
viability dye-pacific blue, CD24-APC, CD44-PE, and CD10-FITC. Each single-color control was run in 
parallel to ensure proper compensation. Cells were gated using forward scatter (FSC) and side scatter 
(SSC) and then gated for the pacific blue negative viable cells. Next, CD24-APC+ cells were gated and 
sorted for other studies. The remaining CD24-APC negative cells were gated for CD10-FITC+CD44-
PE+ and CD10-FITC+CD44-PE- cells and sorted. d, viSNE maps of CyTOF analysis of normal breast 
tissues (CD45 negative population) colored for the indicated markers. Color scale indicates minimum 
and maximum values  of expression in both panels (d and e). e, viSNE maps of CyTOF analysis of 
myoepithelium (CK8/18 negative, E-Cadherin+, SMA+ population) colored for the indicated markers. f, 
Heatmap depicting unsupervised clustering of samples based on the expression of top 1,000 most 
variable genes. Scale indicates relative log2 fold changes of gene expression, white is median of all 
samples and red/blue are relative to median of all samples. g, Pathways enriched in genes differentially 
expressed between the indicated groups of samples. Color scale corresponds to -log (p-value) of 
significance of enrichment, calculated by MetaCore Enrichment Analysis test.  h, Gene tracks (189.501-
189.533Mb) depicting TP63 isoforms in normal breast and in MCF10DCIS cells. i, Gene tracks 
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Tissue Factor signaling in cancer via PAR1 and PAR2
Signal transduction_Soluble CXCL16 signaling
Signal transduction_IP3 signaling
Role of tumor microenvironment in plexiform neurofibroma formation in NF1
Role of growth factor receptors activation by HA/CD44 signaling in tumor progression
Gonadotropin−releasing hormone signaling
Regulation of GSK3 beta in bipolar disorder
Protein folding and maturation_POMC processing
NGF/ TrkA MAPK−mediated signaling
TLR5, TLR7, TLR8 and TLR9 signaling pathways
TLR2 and TLR4 signaling pathways
Oncostatin M signaling via MAPK in human cells




ETV3 affect on CSF1−promoted macrophage differentiation
C5a signaling
Thromboxane A2 signaling pathway
Role of IL−8 in angiogenesis
PDGF signaling via STATs and NF−kB
Oligodendrocyte differentiation from adult stem cells
Notch Signaling Pathway
Negative regulation of Hippo pathway and positive regulation of YAP/TAZ function




Beta−adrenergic receptors transactivation of EGFR
Adenosine A2B receptor signaling




Apoptosis and survival_BAD phosphorylation
mTORC1 upstream signaling
IL−17 signaling pathways
Androgen Receptor nuclear signaling
TGF, WNT and cytoskeletal remodeling
Normal and pathological TGF−beta−mediated regulation of cell proliferation
MIF−induced cell adhesion, migration and angiogenesis
Gastrin in inflammatory response
Gastrin in cell growth and proliferation



































































































































































































































Supplementary Figure 2. Gene expression and p63 and TCF7 binding patterns in DCIS and 
BRCA mutation carriers. a, Heatmap depicting unsupervised clustering of normal and DCIS-
associated CD10+ cells based on the expression of top 1,000 most variable genes. Scale indicates 
relative log2 fold changes of gene expression, white is median of all samples and red/blue are relative 
to median of all samples. b, Venn diagrams indicating the numbers of p63 and TCF7 binding sites 





Supplementary Figure 3. Genomic targets of p63 in MCF10DCIS cells. a, Immunoblot analysis of 
p63 and TCF7 expression in MCF10DCIS cells and three different shTP63-expressing derivatives. 
Jurkat cells were used as positive control for TCF7. ACTB is loading control. b, Pathways enriched in 
genes associated with p63 and H3K27ac overlapping peaks. c, Associations between SE ranking, p63 
binding sites, and gene expression levels. d, Pathway enrichment analysis of p63 genomic targets 




Supplementary Figure 4. Genomic targets of TCF7 in MCF10DCIS cells. a, Gating strategy for the 
identification of cell cycle distribution. Cells were first gated based on 7-AAD-height/7-AAD-area to 
identify single cells (gate: singlets). Following, single cells were shown for BrdU-FITC and 7-AAD-A  
and gated as S-Phase (BrdU-FITC-positive), G1-phase (BrdU-FITC-negative; single 7-AAD content) 
and G2/M-phase (BrdU-FITC-negative; double 7-AAD content). b, Relative fraction of cells in different 
phases of the cell cycle before and after 5 days of doxycycline treatment to induce shTP63 and TCF7, 
respectively. c, Predicted protein interaction network of TFs identified as core transcriptional regulatory 
circuits in MCF10DCIS cells expressing TCF7. Legend indicates the source of data used to determine 
interactions. TFs that are not part of the network were removed.  d, Heatmap depicting p63 and TCF7 
unique peaks and overlapping peaks in MCF10DCIS cells. e, Venn diagram indicating the numbers of 
p63 and TCF7 unique and overlapping binding sites in MCF10DCIS cells. f, Dot plot depicting results 
of cell migration and invasion experiments at different time points following the induction of shTP63 or 
TCF7 by doxycycline (DOX). g, Dot plot depicting results of cell adhesion to different matrices 
experiments at different time points following the induction of shTP63 or TCF7 by doxycycline (DOX). 
P-values indicate statistical significance of difference to no DOX determined by t-test. h, Simplified 
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